Published in Cancer Weekly, June 24th, 2003
These results offer significant hope for people with the aggressive form of NHL, one of the most common types of blood cancer of the lymphatic system. Current medical opinion indicates that if patients survive past the 2-year landmark their chance of a cure can be up to 90%.
Results from the pivotal GELA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.